March 5 (Reuters) - Modern Chinese Medicine Group Co Ltd
:
* EXPECT INCREASE OF NOT LESS THAN 30% IN NET PROFIT ATTRIBUTABLE FOR YEAR
* EXPECTED INCREASE IN NET PROFIT DUE TO SURGE IN SALES OF ADDITIONAL INGREDIENT HUOXIANG ZHENGQI PILL
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
精彩评论